A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations.

Nat Commun · 2022 · PMC9663578 · PMID 36376325

Europe PMC DOI

hedged sentence

0.1007

closest p · 2.0× alpha

0.1007

boldest claim

The sentences

did not reach statistical significanceP = 0.1007not close (p > 0.1)

Moreover, despite a small decrease in the mean ratio of EGFR(+) was observed in patients who were non-responders (SD or PD), these differences did not reach statistical significance (non-responders: 21.6 ± 28.9% vs. responders: 56.2 ± 11.5%, P = 0.1007; Fig. 6f ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.